United States · FDA National Drug Code directory

Namzaric

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0456-1221_00cae29c-d07a-484b-b279-be68f15c5e73
Product NDC
0456-1221
Form
CAPSULE
Composition / generic term
memantine hydrochloride and donepezil hydrochloride
Labeler
Allergan, Inc.
Marketing category
NDA
Marketing start / end (source format)
20160718
Source listing expiry
20271231

Source-listed ingredients

  • MEMANTINE HYDROCHLORIDE — 21 mg/1
  • DONEPEZIL HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE in 1 BOTTLE (0456-1221-30) · 0456-1221-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →